Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

The primary objective of this study is to evaluate the lung cancer diagnosis rate in individuals 40-54 years of age at their first screening (T0) with mobile low-dose CT. Secondary objectives include evaluating the lung cancer diagnosis rate in individuals 40-54 years of age at subsequent screening visits (T1 and T2); evaluating the positive screening rate at T0, T1, and T2; evaluating the impact of baseline demographic (including insurance status), socioeconomic, and healthcare-related factors on lung cancer rates and positive screening rates; and summarizing the incidence rate of all types of cancer found with low-dose lung CT during lung cancer screening. Enrollment will continue until 174 subjects are identified in the evaluable population with a total of 1160 subjects anticipated to be enrolled and screened.

Inclusion criteria

• Subject must meet all the following applicable inclusion criteria to participate in this study:

• Written informed consent and HIPAA authorization for release of personal health information. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.
• Age 40-54 years at the time of consent.
• A positive smoking history of greater/equal to 30 pack years and they are either currently smoking or have quit within the last 15 years.
• Ability to read and understand the English and/or Spanish language.
• Ability to understand and comply with study procedures for the entire length of the study.

Exclusion criteria

• Subjects meeting any of the criteria below may not participate in the study:

• Known diagnosis of lung cancer in the past 5 years.
• Any known contraindication to having a low-dose CT Scan.
• Known pregnancy.